Cytokinetics (CYTK) Cash & Equivalents (2009 - 2026)
Cytokinetics (CYTK) posted Cash & Equivalents of $203.43 million for Q3 2026, down 9.8% from $225.47 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics' Cash & Equivalents came in at $122.52 million, up 28.7% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- In prior years, Cytokinetics' Cash & Equivalents was $95.23 million in FY2024 (-16.0%), $113.4 million in FY2023 (+68.8%), $67.18 million in FY2022 (-40.4%) and $112.67 million in FY2021 (+35.8%).
- Quarterly Cash & Equivalents has run from a low of $47.26 million in Q3 2024 to a high of $255.27 million in Q2 2026 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 73.8%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2025, with growth of 377.0%; the weakest was Q2 2025, with a decline of 59.8%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $255.27 million (Q2 2026), $129.84 million (Q1 2026) and $122.52 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Cytokinetics | 7.83 Bn | 3.24 Bn | 47.10 Mn | 203.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 203.43 Mn |
| Jun 30, 2026 | 255.27 Mn |
| Mar 31, 2026 | 129.84 Mn |
| Dec 31, 2025 | 122.52 Mn |
| Sep 30, 2025 | 225.47 Mn |
| Jun 30, 2025 | 76.55 Mn |
| Mar 31, 2025 | 74.06 Mn |
| Dec 31, 2024 | 95.23 Mn |
| Sep 30, 2024 | 47.26 Mn |
| Jun 30, 2024 | 190.52 Mn |
| Mar 31, 2024 | 120.35 Mn |
| Dec 31, 2023 | 113.40 Mn |
| Sep 30, 2023 | 100.07 Mn |
| Jun 30, 2023 | 69.01 Mn |
| Mar 31, 2023 | 103.22 Mn |
| Dec 31, 2022 | 67.18 Mn |
| Sep 30, 2022 | 106.24 Mn |
| Jun 30, 2022 | 93.63 Mn |
| Mar 31, 2022 | 115.42 Mn |
| Dec 31, 2021 | 112.67 Mn |
API Access
Cytokinetics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();